Literature DB >> 19435724

Diagnostic value of procalcitonin for differentiation between bacterial infection and non-infectious inflammation in febrile patients with active adult-onset Still's disease.

D-Y Chen, Y-M Chen, W-L Ho, H-H Chen, G-H Shen, J-L Lan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19435724     DOI： 10.1136/ard.2008.098335

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  14 in total

Review 1.  Validation of new biomarkers in systemic autoimmune diseases.

Authors:  Maria G Tektonidou; Michael M Ward
Journal:  Nat Rev Rheumatol       Date:  2011-11-01       Impact factor: 20.543

Review 2.  Use of plasma procalcitonin levels as an adjunct to clinical microbiology.

Authors:  David N Gilbert
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

3.  Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.

Authors:  Yizhi Xiao; Hui Luo; Bin Zhou; Xiaodan Dai; Jing Huang; Liping Duan; Yunhui You; Weiru Zhang; Hongjun Zhao; Yanli Xie; Yaou Zhou; Wangbin Ning; Tong Li; Sijia Liu; Honglin Zhu; Xiaoyun Xie; Ying Jiang; Shiyao Wu; Weijia He; Yisha Li
Journal:  Rheumatol Int       Date:  2016-11-22       Impact factor: 2.631

4.  Evaluation of serum procalcitonin and C-reactive protein levels as biomarkers of Henoch-Schönlein purpura in pediatric patients.

Authors:  Xu Teng; Yang Wang; Nan Lin; Mei Sun; Jie Wu
Journal:  Clin Rheumatol       Date:  2014-10-03       Impact factor: 2.980

5.  Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications.

Authors:  Xuefeng B Ling; Jane L Park; Tanya Carroll; Khoa D Nguyen; Kenneth Lau; Claudia Macaubas; Edward Chen; Tzielan Lee; Christy Sandborg; Diana Milojevic; John T Kanegaye; Susanna Gao; Jane Burns; James Schilling; Elizabeth D Mellins
Journal:  Proteomics       Date:  2010-11-23       Impact factor: 3.984

6.  The relationship between procalcitonin and thyroid autoantibodies in patients with autoimmune thyroiditis.

Authors:  Ali Oncul; Ihsan Ates; Mehmet Fettah Arikan; Nisbet Yilmaz; Canan Topcuoglu; Fatma Meric Yilmaz; Mustafa Altay
Journal:  J Clin Lab Anal       Date:  2017-02-07       Impact factor: 2.352

Review 7.  The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis.

Authors:  C-J Shen; M-S Wu; K-H Lin; W-L Lin; H-C Chen; J-Y Wu; M C-H Lee; C-C Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-21       Impact factor: 3.267

8.  Comparison of biomarkers for systemic juvenile idiopathic arthritis.

Authors:  Susan Shenoi; Jing-Ni Ou; Chester Ni; Claudia Macaubas; Vivian H Gersuk; Carol A Wallace; Elizabeth D Mellins; Anne M Stevens
Journal:  Pediatr Res       Date:  2015-08-12       Impact factor: 3.756

9.  Serum procalcitonin for differentiating bacterial infection from disease flares in patients with autoimmune diseases.

Authors:  Kowoon Joo; Won Park; Mie-Jin Lim; Seong-Ryul Kwon; Jiyeol Yoon
Journal:  J Korean Med Sci       Date:  2011-09-01       Impact factor: 2.153

10.  High Level Serum Procalcitonin Associated Gouty Arthritis Susceptibility: From a Southern Chinese Han Population.

Authors:  Wen Liu; Keshav Raj Sigdel; Ying Wang; Qun Su; Yan Huang; Yan Lin Zhang; Jie Chen; Lihua Duan; Guixiu Shi
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.